TNF inhibition and sepsis — sounding a cautionary note
- 1 November 1997
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 3 (11) , 1193-1195
- https://doi.org/10.1038/nm1197-1193
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Two tumour necrosis factor receptors: structure and functionPublished by Elsevier ,2000
- Monocyte deactivation in septic patients: Restoration by IFN-γ treatmentNature Medicine, 1997
- p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic ShockJAMA, 1997
- p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study GroupPublished by American Medical Association (AMA) ,1997
- A MEMBRANE TNF-α/TNFR RATIO CORRELATES TO MODS SCORE AND MORTALITYShock, 1996
- Acute-phase gene expression correlates with intrahepatic tumor necrosis factor-alpha abundance but not with plasma tumor necrosis factor concentrations during sepsis/systemic inflammatory response syndrome in the ratCritical Care Medicine, 1996
- Do monoclonal antibodies and anticytokines still have a future in infectious diseases?The American Journal of Medicine, 1995
- Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.The Journal of Experimental Medicine, 1994
- Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide‐induced lethalityEuropean Journal of Immunology, 1991
- Dissociation between plasma and monocyte‐associated cytokines during sepsisEuropean Journal of Immunology, 1991